The Journal of pediatrics
-
The Journal of pediatrics · Oct 1997
Multicenter Study Clinical TrialSafety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation. The Flumazenil Pediatric Study Group.
To determine the safety and efficacy of flumazenil when given for reversal of benzodiazepine-induced conscious sedation in children. ⋯ Flumazenil promptly and effectively reverses the central nervous system depressant effects of midazolam in children undergoing conscious sedation, with no significant adverse effects. Because of the potential for resedation, children who receive flumazenil should be monitored for 1 to 2 hours after its administration.
-
The Journal of pediatrics · Oct 1997
Randomized Controlled Trial Comparative Study Clinical TrialThe Pediatric Risk of Mortality III--Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients.
To develop a physiology-based measure of physiologic instability for use in pediatric patients that has an expanded scale compared with the Pediatric Risk of Mortality (PRISM) III score. ⋯ The PRISM III-APS score is an expanded measure of physiologic instability that has been validated against mortality. Compared with PRISM III, PRISM III-APS should be more sensitive to small changes in physiologic status.
-
The Journal of pediatrics · Oct 1997
Comparative Study Clinical TrialRapid estimation of insertional length of endotracheal intubation in newborn infants.
To create a simple and accurate method of predicting the correct insertional length of endotracheal intubation during resuscitation of neonates. ⋯ During resuscitation of the neonate when vital parameters are difficult to obtain, the insertional length of endotracheal intubation can be quickly and accurately predicted by nasal-tragus length or sternal length.